We are international
Donate
TEXT SIZE   
   back

Dr. Zonder - Phase I Trial of HuLuc63 in Multiple Myeloma
Jeffrey A. Zonder, MD
Karmanos Cancer Institute
Detroit, Michigan
12.22.07

Be the first to comment

 related articles